HK1070352A1 - Indole-2-carboxamides as factor xa inhibitors - Google Patents
Indole-2-carboxamides as factor xa inhibitorsInfo
- Publication number
- HK1070352A1 HK1070352A1 HK05102886A HK05102886A HK1070352A1 HK 1070352 A1 HK1070352 A1 HK 1070352A1 HK 05102886 A HK05102886 A HK 05102886A HK 05102886 A HK05102886 A HK 05102886A HK 1070352 A1 HK1070352 A1 HK 1070352A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- carboxamides
- indole
- inhibitors
- factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/622—Forming processes; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/626—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B
- C04B35/63—Preparing or treating the powders individually or as batches ; preparing or treating macroscopic reinforcing agents for ceramic products, e.g. fibres; mechanical aspects section B using additives specially adapted for forming the products, e.g.. binder binders
- C04B35/632—Organic additives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/22—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an aralkyl radical attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01127809A EP1314733A1 (en) | 2001-11-22 | 2001-11-22 | Indole-2-carboxamides as factor Xa inhibitors |
PCT/EP2002/012500 WO2003044014A1 (en) | 2001-11-22 | 2002-11-08 | Indole-2-carboxamides as factor xa inhibitors |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1070352A1 true HK1070352A1 (en) | 2005-06-17 |
Family
ID=8179313
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05102886A HK1070352A1 (en) | 2001-11-22 | 2005-04-07 | Indole-2-carboxamides as factor xa inhibitors |
Country Status (31)
Country | Link |
---|---|
US (3) | US6906084B2 (en) |
EP (2) | EP1314733A1 (en) |
JP (1) | JP4664592B2 (en) |
KR (2) | KR100954508B1 (en) |
CN (1) | CN1283638C (en) |
AR (1) | AR037656A1 (en) |
AU (1) | AU2002351918B2 (en) |
BR (1) | BR0214396A (en) |
CA (1) | CA2467374C (en) |
CO (1) | CO5580764A2 (en) |
EC (1) | ECSP045115A (en) |
HK (1) | HK1070352A1 (en) |
HR (1) | HRP20040453A2 (en) |
HU (1) | HUP0402063A3 (en) |
IL (2) | IL162105A0 (en) |
MA (1) | MA27350A1 (en) |
ME (1) | MEP43008A (en) |
MX (1) | MXPA04004797A (en) |
MY (1) | MY131516A (en) |
NO (1) | NO327466B1 (en) |
NZ (1) | NZ533044A (en) |
OA (1) | OA12727A (en) |
PE (1) | PE20030593A1 (en) |
PL (1) | PL210986B1 (en) |
RS (1) | RS40404A (en) |
RU (1) | RU2299881C2 (en) |
TN (1) | TNSN04091A1 (en) |
TW (1) | TWI291950B (en) |
UA (1) | UA78731C2 (en) |
WO (1) | WO2003044014A1 (en) |
ZA (1) | ZA200402945B (en) |
Families Citing this family (73)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20050044417A (en) | 2001-11-14 | 2005-05-12 | 쉐링 코포레이션 | Cannabinoid receptor ligands |
US7358268B2 (en) * | 2002-12-04 | 2008-04-15 | Sanofi-Aventis Deutschland Gmbh | Imidazole derivatives as factor Xa inhibitors |
US7429581B2 (en) * | 2002-12-23 | 2008-09-30 | Sanofi-Aventis Deutschland Gmbh | Pyrazole-derivatives as factor Xa inhibitors |
WO2004072069A1 (en) | 2003-02-14 | 2004-08-26 | Glaxo Group Limited | Carboxamide derivatives |
US7539725B2 (en) * | 2003-04-03 | 2009-05-26 | Zix Corporation | Auditor system |
US7317027B2 (en) * | 2003-05-19 | 2008-01-08 | Sanofi-Aventis Deutschland Gmbh | Azaindole-derivatives as factor Xa inhibitors |
EP1479675A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Indazole-derivatives as factor Xa inhibitors |
US7223780B2 (en) * | 2003-05-19 | 2007-05-29 | Sanofi-Aventis Deutschland Gmbh | Triazole-derivatives as blood clotting enzyme factor Xa inhibitors |
EP1479680A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | Azaindole derivatives as Factor Xa inhibitors |
US7741341B2 (en) | 2003-05-19 | 2010-06-22 | Sanofi-Aventis Deutschland Gmbh | Benzimidazole-derivatives as factor Xa inhibitors |
EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
TWI372050B (en) | 2003-07-03 | 2012-09-11 | Astex Therapeutics Ltd | (morpholin-4-ylmethyl-1h-benzimidazol-2-yl)-1h-pyrazoles |
EP1568698A1 (en) * | 2004-02-27 | 2005-08-31 | Aventis Pharma Deutschland GmbH | Pyrrole-derivatives as factor Xa inhibitors |
EP1571154A1 (en) * | 2004-03-03 | 2005-09-07 | Aventis Pharma Deutschland GmbH | Beta-aminoacid-derivatives as factor Xa inhibitors |
RU2007101705A (en) | 2004-06-18 | 2008-07-27 | Биолипокс Аб (Se) | INDOS USEFUL FOR TREATING INFLAMMATION |
US7868037B2 (en) | 2004-07-14 | 2011-01-11 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7781478B2 (en) | 2004-07-14 | 2010-08-24 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
US7772271B2 (en) * | 2004-07-14 | 2010-08-10 | Ptc Therapeutics, Inc. | Methods for treating hepatitis C |
BRPI0511834A (en) | 2004-07-14 | 2008-01-08 | Ptc Therapeutics Inc | methods for treating hepatitis c |
EP1781289A1 (en) | 2004-07-22 | 2007-05-09 | PTC Therapeutics, Inc. | Thienopyridines for treating hepatitis c |
FR2874015B1 (en) * | 2004-08-05 | 2006-09-15 | Sanofi Synthelabo | N- (1H-INDOLYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
CN101087609B (en) | 2004-10-26 | 2012-11-14 | 詹森药业有限公司 | Factor Xa compounds |
DE602005009252D1 (en) * | 2004-12-08 | 2008-10-02 | Bristol Myers Squibb Co | Heterocyclic Compounds as Inhibitors of Factor VIIA |
EP1833819A1 (en) | 2004-12-30 | 2007-09-19 | Astex Therapeutics Limited | Pyrazole compounds that modulate the activity of cdk, gsk and aurora kinases |
FR2880625B1 (en) * | 2005-01-07 | 2007-03-09 | Sanofi Aventis Sa | N- (HETEROARYL) -1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
DE602005026867D1 (en) | 2005-01-19 | 2011-04-21 | Biolipox Ab | INFLAMMATORY INDOL DERIVATIVES |
JP5094394B2 (en) | 2005-04-20 | 2012-12-12 | 武田薬品工業株式会社 | Fused heterocyclic compounds |
FR2888847B1 (en) | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | N- (HETERIARYL) -1-HETEORARYLALKYL-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION |
US8399666B2 (en) | 2005-11-04 | 2013-03-19 | Panmira Pharmaceuticals, Llc | 5-lipoxygenase-activating protein (FLAP) inhibitors |
GB2431927B (en) | 2005-11-04 | 2010-03-17 | Amira Pharmaceuticals Inc | 5-Lipoxygenase-activating protein (FLAP) inhibitors |
US7977359B2 (en) | 2005-11-04 | 2011-07-12 | Amira Pharmaceuticals, Inc. | 5-lipdxygenase-activating protein (FLAP) inhibitors |
JP5474354B2 (en) | 2005-12-30 | 2014-04-16 | アステックス、セラピューティックス、リミテッド | Pharmaceutical compounds |
CA2637933C (en) * | 2006-01-24 | 2013-03-12 | Eli Lilly And Company | Indole sulfonamide modulators of progesterone receptors |
US7943622B2 (en) | 2006-06-06 | 2011-05-17 | Cornerstone Therapeutics, Inc. | Piperazines, pharmaceutical compositions and methods of use thereof |
EP2049119A2 (en) | 2006-06-29 | 2009-04-22 | Astex Therapeutics Limited | Pharmaceutical combinations of 1-cyclopropyl-3-[3-(5-morphoolin-4-ylmethyl-1h-benzoimidazol-2-yl)-1h-1-pyrazol-4-yl]-urea |
EP3243814B1 (en) | 2007-04-16 | 2018-10-17 | AbbVie Inc. | 7-substituted indole as mcl-1 inhibitors |
BRPI0812594A2 (en) * | 2007-08-10 | 2015-06-23 | Lundbeck & Co As H | Compound or salt or hydrate thereof, pharmaceutical composition, methods for modulating p2x7 receptor activity, for treating a condition responsive to p2x7 receptor modulation in a patient, for inhibiting retinal ganglionic cell death in a patient for determination the presence or absence of a p2x7 receptor in a sample, packaged pharmaceutical preparation, and use of a compound or salt or hydrate thereof. |
TW200920369A (en) | 2007-10-26 | 2009-05-16 | Amira Pharmaceuticals Inc | 5-lipoxygenase activating protein (flap) inhibitor |
KR20100097195A (en) * | 2007-12-07 | 2010-09-02 | 애보트 게엠베하 운트 콤파니 카게 | 5-halogen-substituted oxindole derivatives and use thereof for treating vasopressine-dependent diseases |
BRPI0821431A8 (en) * | 2007-12-27 | 2015-09-22 | Abbott Gmbh & Co Kg | substituted oxindole derivatives and their use for the treatment of vasopressin-dependent diseases. |
CN101952275B (en) | 2008-02-22 | 2014-06-18 | 弗·哈夫曼-拉罗切有限公司 | Modulators for amyloid protein beta |
CN102137858B (en) | 2008-05-23 | 2014-07-23 | 潘米拉制药有限责任公司 | 5-lipoxygenase-activating protein inhibitor |
GB0813144D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
GB0813142D0 (en) | 2008-07-17 | 2008-08-27 | Glaxo Group Ltd | Novel compounds |
SG177384A1 (en) | 2009-06-29 | 2012-02-28 | Incyte Corp | Pyrimidinones as pi3k inhibitors |
WO2011075643A1 (en) | 2009-12-18 | 2011-06-23 | Incyte Corporation | Substituted heteroaryl fused derivatives as pi3k inhibitors |
US8486967B2 (en) | 2010-02-17 | 2013-07-16 | Hoffmann-La Roche Inc. | Heteroaryl substituted piperidines |
EP2558463A1 (en) | 2010-04-14 | 2013-02-20 | Incyte Corporation | Fused derivatives as i3 inhibitors |
US9062055B2 (en) | 2010-06-21 | 2015-06-23 | Incyte Corporation | Fused pyrrole derivatives as PI3K inhibitors |
TW201249844A (en) | 2010-12-20 | 2012-12-16 | Incyte Corp | N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors |
US9108984B2 (en) | 2011-03-14 | 2015-08-18 | Incyte Corporation | Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors |
US9126948B2 (en) | 2011-03-25 | 2015-09-08 | Incyte Holdings Corporation | Pyrimidine-4,6-diamine derivatives as PI3K inhibitors |
FR2974576B1 (en) * | 2011-04-29 | 2013-07-19 | Sanofi Aventis | N - [(1H-PYRAZOL-1-YL) ARYL] -1H-INDOLE OR 1H-INDAZOLE-3-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATIONS |
MX2020004502A (en) | 2011-09-02 | 2022-01-20 | Incyte Holdings Corp | Heterocyclylamines as pi3k inhibitors. |
AU2013226013B2 (en) * | 2012-02-29 | 2016-08-11 | Baruch S. Blumberg Institute | Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation and Their Method of Use |
AR090548A1 (en) | 2012-04-02 | 2014-11-19 | Incyte Corp | BICYCLIC AZAHETEROCICLOBENCILAMINS AS PI3K INHIBITORS |
AU2014233437B2 (en) | 2013-03-15 | 2018-07-26 | Opna Immuno Oncology, SA | Heterocyclic compounds and uses thereof |
US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
EP3085700B1 (en) * | 2013-12-20 | 2018-10-31 | Institute of Pharmacology and Toxicology Academy of Military Medical Sciences P.L.A. China | Novel piperidine carboxamide compound, preparation method, and usage thereof |
US9938272B2 (en) | 2014-05-22 | 2018-04-10 | North China Pharmaceutical Company., Ltd. | Hydrazine compound as blood coagulation factor Xa inhibitor |
WO2015191677A1 (en) | 2014-06-11 | 2015-12-17 | Incyte Corporation | Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors |
EA201790317A1 (en) * | 2014-09-10 | 2018-07-31 | Эпизим, Инк. | SMYD INHIBITORS |
HUE055662T2 (en) | 2014-12-29 | 2021-12-28 | Us Health | Small molecule inhibitors of lactate dehydrogenase and methods of use thereof |
NZ734993A (en) | 2015-02-27 | 2024-03-22 | Incyte Holdings Corp | Salts of pi3k inhibitor and processes for their preparation |
WO2016183063A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Crystalline forms of a pi3k inhibitor |
WO2016183060A1 (en) | 2015-05-11 | 2016-11-17 | Incyte Corporation | Process for the synthesis of a phosphoinositide 3-kinase inhibitor |
CN107922428B (en) * | 2015-06-25 | 2021-02-05 | 普洛麦格公司 | Thienopyrrole compounds and their use as inhibitors of oplophorus-derived luciferase |
KR101725451B1 (en) * | 2016-05-25 | 2017-04-13 | 한국화학연구원 | N--4--1H--2- - N-piperidin-4-yl-1H-indole-2-carboxamide derivatives preparation method thereof and pharmaceutical composition for use in preventing or treating Urotensin- receptor activity related diseases containing the same as an active ingredient |
US11230684B2 (en) * | 2016-10-18 | 2022-01-25 | Chevron Oronite Technology B.V. | Marine diesel lubricant oil compositions |
EP3562823B1 (en) | 2016-12-28 | 2023-02-08 | Promega Corporation | Functionalized nanoluc inhibitors |
JP2020536917A (en) | 2017-10-13 | 2020-12-17 | プレキシコン インコーポレーテッドPlexxikon Inc. | Solid form of compound for regulating kinases |
CN116332818B (en) * | 2021-12-22 | 2023-12-15 | 王喆明 | Tetrahydropyrrole derivatives and their use |
Family Cites Families (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3317524A (en) * | 1965-02-04 | 1967-05-02 | American Home Prod | Substituted 1, 2, 3, 4-tetrahydro-pyrazino[1, 2-a]indoles |
FR2260332A1 (en) * | 1974-02-12 | 1975-09-05 | Delalande Sa | 1-Phenyl-2-aminocarbonyl-indoles - with respiratory analeptic, antiinflammatory analgesic, vasodilator, diuretic and anti-ulcer activity |
US4675332A (en) * | 1984-12-10 | 1987-06-23 | Warner-Lambert Company | Acidic tetrazolyl substituted indole compounds and their use as antiallergy agents |
IE68593B1 (en) * | 1989-12-06 | 1996-06-26 | Sanofi Sa | Heterocyclic substituted acylaminothiazoles their preparation and pharmaceutical compositions containing them |
US5506134A (en) | 1990-10-22 | 1996-04-09 | Corvas International, Inc. | Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
US5788965A (en) | 1991-02-28 | 1998-08-04 | Novo Nordisk A/S | Modified factor VII |
US5833982A (en) | 1991-02-28 | 1998-11-10 | Zymogenetics, Inc. | Modified factor VII |
TW229140B (en) * | 1992-06-05 | 1994-09-01 | Shell Internat Res Schappej B V | |
FR2703995B1 (en) * | 1993-04-16 | 1995-07-21 | Sanofi Elf | 5-ACYLAMINO 1,2,4-THIADIAZOLES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
US5518231A (en) | 1993-04-19 | 1996-05-21 | Xerox Corporation | Self adjusting sheet gripping apparatus |
EP0758341B1 (en) | 1994-04-26 | 2004-03-24 | Aventis Pharmaceuticals, Inc. | FACTOR Xa INHIBITORS |
WO1997003965A1 (en) * | 1995-07-18 | 1997-02-06 | Kyowa Hakko Kogyo Co., Ltd. | Indole derivatives |
JPH0987282A (en) * | 1995-09-21 | 1997-03-31 | Kyowa Hakko Kogyo Co Ltd | Thiazole derivative |
AU2898297A (en) * | 1996-05-24 | 1998-01-05 | Novartis Ag | Use of substance p antagonists for treating social phobia |
FR2763337B1 (en) * | 1997-05-13 | 1999-08-20 | Sanofi Sa | NOVEL TRIAZOLE DERIVATIVES, A PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
GB9716657D0 (en) * | 1997-08-07 | 1997-10-15 | Zeneca Ltd | Chemical compounds |
SI1042287T1 (en) * | 1997-12-24 | 2005-10-31 | Aventis Pharma Deutschland Gmbh | Indole derivatives as inhibitors of factor xa |
HUP0101810A3 (en) | 1998-01-27 | 2002-05-28 | Aventis Pharm Prod Inc | Substituted oxoazaheterocyclyl factor xa inhibitors and pharmaceutical compositions containing them |
EP0987274A1 (en) | 1998-09-15 | 2000-03-22 | Hoechst Marion Roussel Deutschland GmbH | Factor VIIa Inhibitors |
JP4241970B2 (en) * | 1998-10-30 | 2009-03-18 | 中外製薬株式会社 | Indole derivatives having amide bonds, and mono- or diazaindole derivatives |
JP2001002642A (en) * | 1999-06-21 | 2001-01-09 | Nippon Nohyaku Co Ltd | Heterocyclic dicarboxylic acid diamide derivative, herbicide and its use |
HUP0203375A3 (en) | 1999-07-28 | 2005-03-29 | Aventis Pharm Prod Inc | Substituted oxoazaheterocyclyl compounds |
US6486211B1 (en) * | 1999-10-22 | 2002-11-26 | Smithkline Beecham Corporation | Indole compounds |
WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
US6436965B1 (en) | 2000-03-02 | 2002-08-20 | Merck Frosst Canada & Co. | PDE IV inhibiting amides, compositions and methods of treatment |
JP2004501913A (en) | 2000-06-23 | 2004-01-22 | ブリストル−マイヤーズ スクイブ ファーマ カンパニー | Heteroaryl-phenyl substituted factor Xa inhibitors |
DE10147672A1 (en) * | 2001-09-27 | 2003-04-10 | Bayer Ag | Substituted 2,5-diamidoindoles and their use |
KR20050044417A (en) * | 2001-11-14 | 2005-05-12 | 쉐링 코포레이션 | Cannabinoid receptor ligands |
EP1479677A1 (en) * | 2003-05-19 | 2004-11-24 | Aventis Pharma Deutschland GmbH | New indole derivatives as factor xa inhibitors |
FR2888847B1 (en) * | 2005-07-22 | 2007-08-31 | Sanofi Aventis Sa | N- (HETERIARYL) -1-HETEORARYLALKYL-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC APPLICATION |
FR2911604B1 (en) * | 2007-01-19 | 2009-04-17 | Sanofi Aventis Sa | N- (HETEROARYL-1H-INDOLE-2-CARBOXAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC USE |
-
2001
- 2001-11-22 EP EP01127809A patent/EP1314733A1/en not_active Withdrawn
-
2002
- 2002-08-11 UA UA20040604882A patent/UA78731C2/en unknown
- 2002-11-08 PL PL368949A patent/PL210986B1/en unknown
- 2002-11-08 BR BR0214396-8A patent/BR0214396A/en active Search and Examination
- 2002-11-08 OA OA1200400142A patent/OA12727A/en unknown
- 2002-11-08 IL IL16210502A patent/IL162105A0/en unknown
- 2002-11-08 HU HU0402063A patent/HUP0402063A3/en unknown
- 2002-11-08 AU AU2002351918A patent/AU2002351918B2/en not_active Ceased
- 2002-11-08 RU RU2004118710/04A patent/RU2299881C2/en not_active IP Right Cessation
- 2002-11-08 JP JP2003545651A patent/JP4664592B2/en not_active Expired - Fee Related
- 2002-11-08 NZ NZ533044A patent/NZ533044A/en not_active IP Right Cessation
- 2002-11-08 EP EP02787604.4A patent/EP1451185B1/en not_active Expired - Lifetime
- 2002-11-08 CN CNB028232488A patent/CN1283638C/en not_active Expired - Fee Related
- 2002-11-08 KR KR1020047007838A patent/KR100954508B1/en not_active IP Right Cessation
- 2002-11-08 ME MEP-430/08A patent/MEP43008A/en unknown
- 2002-11-08 KR KR1020107003845A patent/KR101033798B1/en not_active IP Right Cessation
- 2002-11-08 CA CA2467374A patent/CA2467374C/en not_active Expired - Fee Related
- 2002-11-08 MX MXPA04004797A patent/MXPA04004797A/en active IP Right Grant
- 2002-11-08 WO PCT/EP2002/012500 patent/WO2003044014A1/en active Application Filing
- 2002-11-08 RS YUP-404/04A patent/RS40404A/en unknown
- 2002-11-19 PE PE2002001105A patent/PE20030593A1/en not_active Application Discontinuation
- 2002-11-20 TW TW091133782A patent/TWI291950B/en not_active IP Right Cessation
- 2002-11-20 AR ARP020104452A patent/AR037656A1/en active IP Right Grant
- 2002-11-21 US US10/301,397 patent/US6906084B2/en not_active Expired - Lifetime
- 2002-11-22 MY MYPI20024375A patent/MY131516A/en unknown
-
2004
- 2004-04-19 ZA ZA2004/02945A patent/ZA200402945B/en unknown
- 2004-04-22 MA MA27647A patent/MA27350A1/en unknown
- 2004-05-20 IL IL162105A patent/IL162105A/en not_active IP Right Cessation
- 2004-05-20 EC EC2004005115A patent/ECSP045115A/en unknown
- 2004-05-20 CO CO04046947A patent/CO5580764A2/en active IP Right Grant
- 2004-05-21 HR HR20040453A patent/HRP20040453A2/en not_active Application Discontinuation
- 2004-05-21 TN TNP2004000091A patent/TNSN04091A1/en unknown
- 2004-06-21 NO NO20042592A patent/NO327466B1/en not_active IP Right Cessation
- 2004-08-26 US US10/926,909 patent/US20050043302A1/en not_active Abandoned
-
2005
- 2005-04-07 HK HK05102886A patent/HK1070352A1/en not_active IP Right Cessation
-
2008
- 2008-05-12 US US12/119,013 patent/US20090069565A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2002350217A8 (en) | Glycinamides as factor xa inhibitors | |
HK1070352A1 (en) | Indole-2-carboxamides as factor xa inhibitors | |
IL169323A0 (en) | Pyrazole-derivatives as factor xa inhibitors | |
AU2001273040A1 (en) | Factor xa inhibitors | |
HK1061973A1 (en) | Lactam-containing compounds and derivatives thereof as factor xa inhibitors | |
EG25482A (en) | Inhibitors | |
GB0229015D0 (en) | New Compound | |
AU2002365896A8 (en) | Substituted amino methyl factor xa inhibitors | |
IL162454A0 (en) | Pyrrolidine-2-ones as factor xa inhibitors | |
IL159195A0 (en) | Pyrrolidine derivatives as factor xa inhibitors | |
HK1089174A1 (en) | Benzimidazole-derivatives as factor xa inhibitors | |
EP1379245A4 (en) | 1, 4, 5, 6-tetrahydropyrazolo- 3, 4-c|-pyrid in-7-ones as factor xa inhibitors | |
PL350941A1 (en) | Pyrazole-3-on-derivative as factor xa inhibitors | |
HK1089175A1 (en) | Azaindole-derivatives as factor xa inhibitors | |
AU2003296393A1 (en) | Factor xa inhibitors | |
GB0104554D0 (en) | New uses | |
AU2002348501A1 (en) | Factor xa inhibitor | |
AU2002325882A1 (en) | Phenyl derivatives as factor Xa inhibitors | |
IL153176A0 (en) | New phenylpiperazines | |
HUP0303185A3 (en) | Glyt-1 inhibitors | |
PL364090A1 (en) | New benzylaminopyrimidines | |
GB0101134D0 (en) | Inhibitors | |
GB0101135D0 (en) | Inhibitors | |
GB0128453D0 (en) | Inhibitors | |
GB0226149D0 (en) | Inhibitors |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20141108 |